Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant-activating mutation.
- DOI
- 10.1002/cti2.1493
- Published
- 2024
- Container
- Clinical & translational immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cti2.1493,
title = {Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant-activating mutation.},
author = {Ashby L and Chan L and Winterbourn C and Woon ST and Keating P and Heller R and Ameratunga R and Chua I and Hsiao KC},
year = {2024},
journal = {Clinical \& translational immunology},
doi = {10.1002/cti2.1493},
url = {https://doi.org/10.1002/cti2.1493}
}RIS
TY - JOUR TI - Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant-activating mutation. AU - Ashby L AU - Chan L AU - Winterbourn C AU - Woon ST AU - Keating P AU - Heller R AU - Ameratunga R AU - Chua I AU - Hsiao KC PY - 2024 JO - Clinical & translational immunology DO - 10.1002/cti2.1493 UR - https://doi.org/10.1002/cti2.1493 ER -
APA
L, A., L, C., C, W., ST, W., P, K., R, H., R, A., I, C., & KC, H. (2024). Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant-activating mutation.. Clinical & translational immunology. https://doi.org/10.1002/cti2.1493